| A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis NNI Philip N Newsome, Kristine Buchholtz, Kenneth Cusi , Martin Linder ... New England Journal of Medicine 384 (doi: 10.1056/NEJMoa2028395), 1113-1124, 2021 | 1491 | 2021 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1213 | 2019 |
| Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study A Dennis, M Wamil, J Alberts, J Oben, DJ Cuthbertson, D Wootton, ... BMJ open 11 (3), e048391, 2021 | 623 | 2021 |
| Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice JA Oben, A Mouralidarane, AM Samuelsson, PJ Matthews, ML Morgan, ... Journal of hepatology 52 (6), 913-920, 2010 | 345 | 2010 |
| Hepatic fibrogenesis requires sympathetic neurotransmitters JA Oben, T Roskams, S Yang, H Lin, N Sinelli, M Torbenson, U Smedh, ... Gut 53 (3), 438-445, 2004 | 291 | 2004 |
| Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis A Hirose, M Ono, T Saibara, Y Nozaki, K Masuda, A Yoshioka, ... Hepatology 45 (6), 1375-1381, 2007 | 285 | 2007 |
| Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1 (7–36) amide, on fatty acid synthesis in explants of rat adipose tissue J Oben, L Morgan, J Fletcher, V Marks Journal of Endocrinology 130 (2), 267-272, 1991 | 246 | 1991 |
| A guide to non-alcoholic fatty liver disease in childhood and adolescence JL Temple, P Cordero, J Li, V Nguyen, JA Oben International journal of molecular sciences 17 (6), 947, 2016 | 241 | 2016 |
| Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice A Mouralidarane, J Soeda, C Visconti‐Pugmire, AM Samuelsson, ... Hepatology 58 (1), 128-138, 2013 | 167 | 2013 |
| Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells JA Oben, S Yang, H Lin, M Ono, AM Diehl Biochemical and biophysical research communications 302 (4), 685-690, 2003 | 140 | 2003 |
| Norepinephrine regulates hepatic innate immune system in leptin‐deficient mice with nonalcoholic steatohepatitis Z Li, JA Oben, S Yang, H Lin, EA Stafford, MJ Soloski, SA Thomas, ... Hepatology 40 (2), 434-441, 2004 | 138 | 2004 |
| Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury JA Oben, T Roskams, S Yang, H Lin, N Sinelli, Z Li, M Torbenson, ... Hepatology 38 (3), 664-673, 2003 | 135 | 2003 |
| Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis PN Newsome, ME Allison, PA Andrews, G Auzinger, CP Day, ... Gut 61 (4), 484-500, 2012 | 117 | 2012 |
| Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells B Sigala, C McKee, J Soeda, V Pazienza, M Morgan, CI Lin, C Selden, ... PloS one 8 (9), e72928, 2013 | 111 | 2013 |
| Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice JA Oben, T Roskams, S Yang, H Lin, N Sinelli, Z Li, M Torbenson, ... Biochemical and biophysical research communications 308 (2), 284-292, 2003 | 110 | 2003 |
| Sympathetic nervous system regulation of liver repair JA Oben, AM Diehl The Anatomical Record Part A: Discoveries in Molecular, Cellular, and …, 2004 | 109 | 2004 |
| Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings C Panebianco, JA Oben, M Vinciguerra, V Pazienza Clinical and experimental medicine 17, 269-280, 2017 | 105 | 2017 |
| Recent advancements in drug treatment of obesity R Carter, A Mouralidarane, S Ray, J Soeda, J Oben Clinical medicine 12 (5), 456-460, 2012 | 89 | 2012 |
| Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease T Asanuma, M Ono, K Kubota, A Hirose, Y Hayashi, T Saibara, O Inanami, ... Gut 59 (2), 258-266, 2010 | 87 | 2010 |
| Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells J Soeda, M Morgan, C McKee, A Mouralidarane, CI Lin, T Roskams, ... Biochemical and biophysical research communications 417 (1), 17-22, 2012 | 86 | 2012 |
